Last Updated on November 27, 2025 by Bilal Hasdemir
Understanding the metrics and influence of key publications is key in oncology research. Cancer Medicine, an open-access journal by John Wiley and Sons Inc., is a top resource in the field of cancer medicine, offering valuable insights and research developments for clinicians and scientists worldwide.
Cancer Medicine plays a big role in sharing important research and cancer treatment advancements. Its open-access model gives critical insights to the medical community and beyond. The journal’s 2025 impact factor is 3.1, as shown on ResearchGate.
At Liv Hospital, we use trusted sources like Cancer Medicine to guide our cancer care. This ensures we’re always up-to-date with the latest research and treatments.
Key Takeaways
- Cancer Medicine is a leading open-access journal in oncology research.
- Published by John Wiley and Sons Inc., it offers valuable insights into cancer treatment advancements.
- The journal’s 2025 impact factor is 3.1.
- Cancer Medicine provides critical information to the medical community through its open-access model.
- It is a trusted resource for staying updated on the latest research and therapeutic developments in oncology.
Overview of Cancer Medicine Journal
Cancer Medicine is a key journal in oncology. It focuses on improving cancer treatment with top-notch research.
The journal is published by John Wiley and Sons Inc., a top name in academic publishing. Its ISSN is 2045-7634, showing its solid place in science.
Publication History and Development
The journal has a long history of publishing detailed research in oncology. It’s known for covering many areas, like biochemistry, genetics, molecular biology, and clinical medicine. This wide range makes it essential for both researchers and doctors.
John Wiley and Sons, Inc. as Publisher
Being published by John Wiley and Sons Inc. boosts the journal’s credibility and reach. The publisher’s skill in handling important papers keeps Cancer Medicine’s standards high.
Thanks to John Wiley and Sons Inc., Cancer Medicine keeps sharing the latest research. It aims to improve cancer treatment and care for patients.
Cancer Medicine Impact Factor 2025: Analysis and Significance
In 2025, Cancer Medicine’s impact factor is 3.1. This shows the journal’s influence and recent trends in oncology research. The value comes from the quality of research and the journal’s reputation in science.
Current Impact Factor of 3.1
The impact factor of 3.1 means articles from Cancer Medicine get cited 3.1 times on average. This is important for researchers and institutions to see the journal’s impact in oncology.
Key aspects of the impact factor include:
- Citation count of recent articles
- Influence on oncology research and clinical practice
- Journal’s standing among peers
Decrease of 0.52 from 2023: Causes and Context
The impact factor of Cancer Medicine dropped by 0.52 from 2023 to 2025. This change is due to several reasons. These include shifts in research trends, changes in how articles are cited, and the journal’s policies.
| Year | Impact Factor | Change |
|---|---|---|
| 2023 | 3.62 | – |
| 2025 | 3.1 | -0.52 |
The trend shows a small change in the impact factor. This is normal in scientific publishing. The decrease might be due to fewer citations or changes in the journal’s focus.
It’s key for authors, researchers, and institutions to understand these changes. This helps them decide where to publish and which journals to follow for cancer research updates.
Comprehensive Journal Metrics for Cancer Medicine
Understanding the metrics of Cancer Medicine is key to seeing its role in oncology research. Different indicators give a full view of the journal’s standing and impact in the scientific world.
H-Index of 95: Meaning and Importance
The H-index measures a journal’s productivity and citation impact. Cancer Medicine’s H-index of 95 shows its big influence in oncology. This high H-index means the journal publishes top-quality, widely-cited research. A journal with an H-index of 95 has at least 95 papers each cited 95 times.
For researchers, this H-index shows Cancer Medicine is a trusted source of impactful studies. It also shows the journal’s ability to publish significant cancer medicine research.
SJR Score of 1.201 and Its Implications
The SCImago Journal Rank (SJR) score measures a journal’s prestige based on citations. Cancer Medicine’s SJR score of 1.201 shows its standing compared to other oncology journals. This score comes from citation data and shows the journal’s reputation and influence.
To understand this SJR score, let’s look at other metrics. The table below shows Cancer Medicine’s metrics alongside others.
| Metric | Value | Description |
|---|---|---|
| H-Index | 95 | Indicates the journal’s productivity and citation impact |
| SJR Score | 1.201 | Reflects the journal’s prestige and citation influence |
| Impact Factor | 3.1 | Measures the average citations received by papers published in the journal |
“The metrics surrounding Cancer Medicine offer insights into its role within the oncology community and its global reach.”
By looking at these journal metrics, we understand Cancer Medicine’s importance in oncology research.
Global Rankings and Position of Cancer Medicine
The global ranking of the Cancer Medicine journal gives us insights into its place among oncology publications. It shows us how influential it is in the oncology world.
Cancer Medicine’s current global rank is a key metric. It shows its impact on cancer research and treatment. The journal is currently ranked 3542 globally, highlighting its role in oncology research.
Current Global Rank of 3542
This ranking shows Cancer Medicine is a respected journal in oncology. The global rank of 3542 proves its dedication to publishing top-notch research. This research helps us better understand cancer and its treatment.
Standing Among Oncology Journals
Cancer Medicine’s standing among other oncology journals is important. It’s known for its strict peer-review process and focus on new oncology research. This has earned it a big following among researchers and doctors.
By keeping its high standards and publishing important research, Cancer Medicine aims to stay at the top. We see this ranking as key. It shows the journal’s big impact on global oncology research.
The Scope and Scientific Focus of Cancer Medicine
We dive into Cancer Medicine, blending biochemistry, genetics, and molecular biology. This mix drives new ideas in fighting cancer.
The journal looks at many areas important for cancer research. It covers biochemistry and genetics to understand cancer’s roots and growth.
Coverage of Biochemistry and Genetics
Cancer Medicine shares key studies in biochemistry and genetics. It shows how these fields help us grasp cancer. It looks at genetic changes and biochemical pathways, and how they affect cancer treatment.
Molecular Biology and Clinical Medicine Content
The journal also explores molecular biology and clinical medicine. This ensures a full view of cancer research. It includes studies on molecular tests, treatments, and clinical trials. These are all key to better cancer care.
By combining these fields, Cancer Medicine helps us understand cancer better. It encourages the creation of effective treatments. The journal’s wide view shows cancer’s complexity and the need for all-around solutions.
Indexing and Academic Recognition
Cancer Medicine is recognized in the Science Citation Index Expanded. This shows its big impact in the scientific world. It proves the journal’s dedication to top-notch research in oncology.
Inclusion in Science Citation Index Expanded
The Science Citation Index Expanded is a top database for many scientific journals. Being in this list is a big win for Cancer Medicine. It:
- Makes the journal more visible to researchers and scholars
- Helps more people around the world access the research
- Boosts the journal’s impact factor and citation numbers
This shows the journal’s strong commitment to cancer research. It also shows its goal to share important scientific findings.
Other Major Database Indexing
Cancer Medicine is also in other key databases for research. These include:
- PubMed
- Scopus
- DOAJ (Directory of Open Access Journals)
- Embase
These databases help spread the journal’s reach and trust. They make sure Cancer Medicine’s research is seen and valued by the scientific community.
Being in these databases makes Cancer Medicine a respected name in oncology. It offers a valuable resource for researchers, doctors, and scholars all over the world.
Open Access Model and Publication Policies
Cancer Medicine is an open-access journal. It offers free access to a vast amount of cancer research. This model has changed how we share and use cancer research worldwide.
Benefits of Open Access for Cancer Research
The open-access model of Cancer Medicine brings many benefits to cancer research. It lets researchers, doctors, and patients see the latest findings without any barriers. This helps global teamwork and improves cancer care.
- Increased Visibility: Open access makes research more visible. This means it’s more likely to be used and built upon.
- Global Reach: Free access to research helps Cancer Medicine reach more people. This includes those in low-resource settings.
- Accelerated Innovation: Open access speeds up the sharing of new research. This quickens innovation in cancer research and treatment.
Article Processing Charges and Funding Options
Cancer Medicine is open-access but has publishing costs. To cover these, the journal charges authors article processing charges (APCs).
We know APCs can be hard for some researchers, like those from low-income countries. So, Cancer Medicine offers funding options and waivers to those who qualify.
| Funding Option | Description | Eligibility |
|---|---|---|
| Full Waiver | Complete waiver of APCs | Authors from low-income countries or with limited funding |
| Partial Waiver | Partial reduction of APCs | Authors with limited funding or those demonstrating financial hardship |
| Discounted Rate | Reduced APCs for members or subscribers | Members or subscribers of the journal or associated societies |
By providing these funding options, we make sure money doesn’t stop important cancer research from being published.
Comparative Analysis with Other Oncology Journals
Cancer Medicine’s impact factor and publication policies stand out when compared to other oncology journals. It’s important to see how it compares to its competitors in the field.
Impact Factor Comparison with Competitor Journals
Cancer Medicine has an impact factor of 3.1, ranking it among the top oncology journals. We compare it to other key journals to understand its position.
| Journal Name | Impact Factor | H-Index |
|---|---|---|
| Cancer Medicine | 3.1 | 95 |
| Journal of Clinical Oncology | 45.3 | 432 |
| Oncology Letters | 3.5 | 63 |
| Cancer Research | 12.7 | 413 |
The table shows Cancer Medicine’s impact factor is competitive. But journals like the Journal of Clinical Oncology have much higher impact factors. Yet, Cancer Medicine’s H-Index of 95 shows its consistent influence.
Unique Features of Cancer Medicine
Cancer Medicine stands out with its open access model. This model makes research findings widely available.
It also focuses on clinical and translational research. This focus helps studies that directly impact cancer treatment and patient care. Its rigorous peer-review process ensures high-quality and relevant research.
Cancer Medicine’s dedication to publishing impactful research makes it valuable for researchers and clinicians. Its unique features and competitive metrics highlight its importance in oncology publications.
Cancer Medicine’s Contribution to Oncology Research
The journal Cancer Medicine is key in moving oncology research forward. It shares groundbreaking studies and discoveries. This leading publication offers insights into cancer research, shaping current and future oncology practices.
Landmark Studies and Research Breakthroughs
Cancer Medicine has published critical research that deepens our understanding of cancer. It has focused on:
- Genetic markers for cancer diagnosis: Finding specific genetic mutations linked to cancers.
- Novel therapeutic approaches: Exploring new treatments like immunotherapy and targeted therapy.
- Cancer epidemiology: Studying cancer types’ incidence and prevalence, helping find risk factors and prevention.
These studies have greatly helped the scientific community understand cancer. They also open doors for new treatments.
Influence on Cancer Treatment Protocols
The research in Cancer Medicine has significantly shaped cancer treatment worldwide. It shares findings from clinical trials and studies. This helps create better treatment guidelines.
For example, studies on new cancer therapies have made them part of treatment plans. This has led to better patient results.
| Research Area | Impact on Treatment Protocols | Examples of Published Studies |
|---|---|---|
| Immunotherapy | New treatment options for various cancers | Studies on checkpoint inhibitors and CAR-T cell therapy |
| Targeted Therapy | Personalized medicine approaches based on genetic profiling | Research on targeted therapies for specific genetic mutations |
| Cancer Epidemiology | Informing prevention strategies and early detection programs | Studies on cancer incidence trends and risk factor analysis |
By publishing top-notch research, Cancer Medicine leads in oncology research. It drives progress in cancer treatment and care.
Publication Process and Author Guidelines
The publication process in Cancer Medicine aims for strict peer review and high standards. We aim to offer a fair, clear, and quick process for authors.
Manuscript Submission Requirements
Authors must follow specific guidelines for manuscript submission to Cancer Medicine. Manuscript preparation should use our template, available on our website. Submissions are made online, where authors must provide details like title, abstract, and keywords.
Key requirements for manuscript submission include:
- Originality and relevance to oncology
- Following the journal’s formatting guidelines
- Ethics statement and conflict of interest disclosure
- A cover letter explaining the research’s significance
Peer Review Process and Timeline
Cancer Medicine uses a double-blind peer review process. This keeps reviewers and authors anonymous, ensuring fairness and integrity.
The peer review timeline is as follows:
| Stage | Timeline |
|---|---|
| Initial Review | 2-3 weeks |
| Peer Review | 4-6 weeks |
| Revision and Resubmission | Variable, depending on the author’s response |
| Final Decision | 1-2 weeks after resubmission |
We know timely publication is key for researchers. Our peer review is fast yet maintains quality standards.
For more detailed author guidelines and to submit your manuscript, please visit our website. We eagerly await your submissions.
Future Trends in Cancer Medicine Journal
Cancer Medicine Journal is on the verge of a new era. It’s driven by new trends and research. As a top publication in oncology, it keeps up with the latest in cancer research and treatment.
We expect it to stay at the top of sharing new research. This will help shape future cancer treatments.
Projected Impact Factor Developments
The impact factor of Cancer Medicine Journal is a big deal. It currently stands at 3.1. We think its impact factor will keep growing, showing its big role in oncology.
Things like the quality of research, how often it’s cited, and its reputation play a part. These all help its impact factor.
Key factors influencing the projected impact factor include:
- Increased visibility through open-access publishing
- Rigorous peer-review process ensuring high-quality research
- Publication of landmark studies and research breakthroughs
Emerging Research Areas and Special Issues
Cancer Medicine Journal will focus on new research areas. These include precision medicine, immunotherapy, and liquid biopsies. These areas could change cancer treatment a lot, making it more targeted and effective.
The journal will likely have special issues on these topics. This will give a detailed look at the latest news.
Some possible special issues could be:
- Advances in Cancer Immunotherapy
- The Role of Genetics in Cancer Treatment
- Emerging Biomarkers for Early Cancer Detection
By covering these new areas, Cancer Medicine Journal will continue to be a key resource. It will help shape the future of cancer care.
Conclusion: The Enduring Value of Cancer Medicine in Oncology Publications
We’ve seen how Cancer Medicine is a key player in oncology. It’s dedicated to moving cancer medicine forward. The journal shares new research that changes how we see and treat cancer.
Cancer Medicine covers many areas, like biochemistry and genetics. It also focuses on clinical medicine. This wide range helps many people, from researchers to doctors. It creates a space where everyone can work together to find new cancer treatments.
Looking ahead, Cancer Medicine will keep being important in cancer research. It offers its research for free and checks it carefully. This makes sure top-quality studies are available to everyone. We see the journal’s big role in fighting cancer and its ongoing impact on the field.
FAQ
What is the impact factor of Cancer Medicine in 2025?
The impact factor of Cancer Medicine in 2025 is 3.1. This shows its importance in oncology research. It also shows its big influence on the medical field.
Who publishes the Cancer Medicine journal?
John Wiley and Sons, Inc. publishes Cancer Medicine. They are known for their top-notch scientific journals.
What is the scope of Cancer Medicine, and what areas does it cover?
Cancer Medicine deals with many topics in oncology. This includes biochemistry, genetics, molecular biology, and clinical medicine. It’s a key resource for both researchers and clinicians.
Why did the impact factor of Cancer Medicine decrease from 2023 to 2025?
The impact factor dropped by 0.52 from 2023 to 2025. This might be due to changes in how research is cited. Or it could be because of new research areas or a shift in the journal’s focus.
What is the h-index of Cancer Medicine, and what does it signify?
Cancer Medicine has an h-index of 95. This means it has many highly cited articles. It shows the journal’s big influence and reputation in oncology research.
Is Cancer Medicine an open-access journal?
Yes, Cancer Medicine is open-access. This means its articles are free for everyone worldwide. It helps spread knowledge and advance cancer research.
Are there any article processing charges for publishing in Cancer Medicine?
Yes, there are article processing fees. But there are also funding options to help authors. This ensures money doesn’t stop important research from being published.
How is Cancer Medicine indexed, and what are the implications?
Cancer Medicine is indexed in the Science Citation Index Expanded and other big databases. This makes it more visible and credible. It also makes it easier for researchers and clinicians worldwide to access.
What are the benefits of publishing in Cancer Medicine?
Publishing in Cancer Medicine has many benefits. It’s open-access, has strict peer review, and is well-respected in oncology. This can lead to high impact and visibility.
How can I submit a manuscript to Cancer Medicine?
To submit a manuscript, use Cancer Medicine’s online system. Follow the journal’s guidelines and go through its peer review process.
What are the future trends and emerging research areas in Cancer Medicine?
Cancer Medicine will likely focus on new areas like precision medicine, immunotherapy, and cancer genomics. This reflects the changing landscape of oncology research.
References
- Wiley Online Library. (2025). Cancer Medicine Journal Metrics. Retrieved October 2025, from https://onlinelibrary.wiley.com/journal/20457634
- JournalSearches. (2024). Cancer Medicine Impact Factor, Indexing, Ranking (2025). Retrieved October 2025, from https://journalsearches.com/journal.php?title=cancer+medicine
